Recombinant IL-6R (Tocilizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all IL-6R (Tocilizumab Biosimilar) products
- IL-6R (Tocilizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL-6R (Tocilizumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Tocilizumab Biosimilar - Anti-IL-6R mAb
- Characteristics
- Antibody Type: IgG1Kappa
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-IL-6R (Tocilizumab Biosimilar) antibody
Reactivity: Human ELISA, InhA Host: Rabbit Monoclonal RhPM-1 unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- 4 °C,-20 °C
- Storage Comment
- 4°C for short term, -20°C for long term
-
- Target
- IL-6R (Tocilizumab Biosimilar)
- Abstract
- IL-6R (Tocilizumab Biosimilar) Products
- Synonyms
- CD126 antibody, IL-6R-1 antibody, IL-6RA antibody, IL6Q antibody, IL6RA antibody, IL6RQ antibody, gp80 antibody, interleukin 6 receptor antibody, IL6R antibody
- Target Type
- Biosimilar
- Background
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. - CAS-No
- 375823-41-9
-
You are here:
